Glucocorticoid inhibition of growth in rats: Partial reversal with the full-length ghrelin analog BIM-28125

Pituitary

Volumn 10, Issue 3, 2007, Pages 267-274

  Tulipano, Giovanni ^a   Taylor, John E ^b   Halem, Heather A ^b   Datta, Rakesh ^b   Dong, Jesse Z ^b   Culler, Michael D ^b   Bianchi, Irene ^a   Cocchi, Daniela ^a   Giustina, Andrea ^a,c  

^a UNIVERSITY OF BRESCIA   (Italy)

^b IPSEN   (France)

^c Spedali Civili di Brescia ^*  (Italy)

Author keywords

Ghrelin; Glucocorticoid; IGF 1; Rat; Somatic growth

Indexed keywords

BIM 28125; DEXAMETHASONE; GHRELIN; SODIUM CHLORIDE; SOMATOMEDIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; BODY WEIGHT; CONTROLLED STUDY; DRUG POTENTIATION; FOOD INTAKE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; GROWTH INHIBITION; GROWTH RATE; HORMONE DETERMINATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN;

ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; CHO CELLS; CRICETINAE; CRICETULUS; DOSE-RESPONSE RELATIONSHIP, DRUG; EATING; EPIDIDYMIS; GHRELIN; GLUCOCORTICOIDS; GROWTH; HORMONE ANTAGONISTS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; OBESITY; PHOSPHATIDYLINOSITOLS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SOMATOTROPIN; RECOMBINANT PROTEINS;

EID: 35848964591     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11102-007-0054-6     Document Type: Article

References (35)

1. Wehrenberg P, Bergman PJ, Stagg L, Ndon J, Giustina A (1990) Glucocorticoid inhibition of growth in rats: Partial reversal with somatostatin antibodies. Endocrinology 127:2705-2708
2. Allen DB (1996) Growth suppression by glucocorticoid therapy. In: Rosenfeld RL (ed) Growth and growth disorders. Saunders, Philadephia, pp 669-718
3. Giustina A, Veldhuis JD (1998) Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the humans. Endocr Rev 19:717-797
4. Muller EE, Locatelli V, Cocchi D (1999) Neuroendocrine control of growth hormone secretion. Physiol Rev 79:3200-3203
5. Tulipano G, Soldi D, Bagnasco M et al (2002) Characterization of new selective somatostatin receptor subtype-2 (sst2) antagonists, BIM-23627 and BIM-23454. Effects of BIM-23627 on GH release in anesthetized male rats after short-term high-dose dexamethasone treatment. Endocrinology 143:1218-1224
6. Tulipano G, Rossi E, Culler MD et al (2005) The somatostatin subtype-2 receptor antagonist, BIM-23627, improves the catabolic effects induced by long-term glucocorticoid treatment in the rat. Regul Peptides 125:85-92
7. Kojima M, Hosoda H, Date Y et al (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656-660
8. Voltz DM, Piering AW, Magestro M et al (1995) Effect of GHRP-6 and GHRH on GH secretion in rats following chronic glucocorticoid treatment. Life Sci 56:491-497
9. Zizzari P, Halem H, Taylor JE et al (2005) Endogenous ghrelin regulates episodic growth hormone (GH) secretion by amplifying GH Pulse amplitude: evidence from antagonism of the GH secretagogue-R1a receptor. Endocrinology 146:3836-3842
10. Tschop M, Smiley DL, Heiman ML (2000) Ghrelin induces adiposity in rodents. Nature 407:908-913
11. Nakazato M, Murakami N, Date Y et al (2001) A role for ghrelin in the central regulation of feeding. Nature 409:194-198
12. Choi K, Roh SG, Hong YH et al (2003) The role of ghrelin and growth hormone secretagogues receptor on rat adipogenesis. Endocrinology 144:754-759
13. Thompson NM, Gill DA, Davies R et al (2004) Ghrelin and des-octanoyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of the type 1a growth hormone secretagogue receptor. Endocrinology 145:234-242
14. Katsuki A, Urakawa H, Gabazza EC et al (2004) Circulating levels of active ghrelin is associated with abdominal adiposity, hyperinsulinemia and insulin resistance in patients with type 2 diabetes mellitus. Eur J Endocrinol 151:573-577
15. Halem HA, Taylor JE, Dong JZ et al (2004) Novel analogs of ghrelin: physiological and clinical implications. Eur J Endocrinol 151:S71-S75
16. Yildiz B, Suchard MA, Wong ML (2004) Alterations in the dynamics of circulating ghrelin, adiponectin, and leptin in human obesity. PNAS USA 101:10434-10439
17. Rubinfeld H, Hadani M, Taylor JE et al (2004) Novel ghrelin analogs with improved affinity for the GH secretagogue receptor stimulate GH and prolactin release from human pituitary cells. Eur J Endocrinol 151:787-795
18. Snider RM, Forray C, Pfenning M, Richelson E (1986) Neurotensin stimulates inositol phospholipid metabolism and calcium mobilization in murine neuroblastoma clone N1E-115. J Neurochem 47:1214-1218
19. Wehrenberg WB, Giustina A (1992) The role of glucocorticoids in the regulation of growth hormone secretion. TEM 3:306-311
20. Giustina A, Bossoni S, Bodini C et al (1992) Arginine normalizes the growth hormone (GH) response to GH-releasing hormone in adult patients receiving chronic daily immunosuppression glucocorticoid therapy. J Clin Endocrinol Metab 74:1301-1305
21. King AP, Carter-Su C (1995) Dexamethasone-induced antagonism of growth hormone (GH) action by down-regulation of GH binding in 3T3-F442A fibroblasts. Endocrinology 136:4796-4803
22. Unterman TG, Philips LS (1985) Glucocorticoids effects on somatomedins and somatomedin inhibitors. J Clin Endocrinol Metab 61:618-626
23. Allen DB, Julius JR, Breen TJ, Attie KM (1998) Treatment of glucocorticoid-induced growth suppression with growth hormone. National cooperative growth study. J Clin Endocrinol Metab 83:2824-2829
24. Giustina A, Bussi AR, Jacobello C, Wehrenberg WB (1995) Effects of recombinant human growth hormone (GH) on bone and intermediary metabolism in patients receiving chronic glucocorticoid treatment with suppressed endogenous GH response to GH-releasing hormone. J Clin Endocrinol Metab 80:122-129
25. Kojima M, Kangawa K (2005) Ghrelin: Structure and function. Physiol Rev 85:495-522
26. Camina JP (2006) Cell biology of the ghrelin receptor. J Neuroendocrinol 18:65-76
27. Barazzoni R, Bosutti A, Stebel M et al (2004) Ghrelin regulates mitochondrial-lipid metabolism gene expression and tissue fat distribution in liver and skeletal muscle. AJP Endocrinol Metab 288:228-235
28. Gauna C, Delhanty PJD, Hofland LJ (2006) Ghrelin stimulates, whereas des-octanoyl ghrelin inhibits, glucose output by primary hepatocytes. J Clin Endocrinol Metab 90:1055-1060
29. Kim MS, Yoon CY, Jang PG (2004) The mitogenic and antiapoptotic actions of ghrelin in 3T3-L1 adipocytes. Mol Endocrinol 18:2291-2301
30. Patel AD, Stanley SA, Murphy KG et al (2006) Ghrelin stimulates insulin-induced glucose uptake in adipocytes. Regul Peptides 134:17-22
31. Maccarinelli G, Sibilia V, Torsello A et al (2005) Ghrelin regulates proliferation and differentiation of osteoblastic cells. J Endocrinol 184:249-256
32. Fukushima N, Hanada R, Teranishi H (2005) Ghrelin directly regulates bone formation. J Bone Miner Res 20:790-798
33. Delhanty PJ, Van der Eerden BC, Van der Velde M et al (2006) Ghrelin and unacylated ghrelin stimulate human osteoblast growth via mitogen-activated protein kinase (MAPK)/phosphoinositide 3-kinase (PI3K) pathways in the absence of GHS-R1a. J Endocrinol 188:37-47
34. Caminos JE, Gualillo O, Lago F (2006) The endogenous growth hormone secretagogue (ghrelin) is synthetized and secreted by chondrocytes. Endocrinology 146:1285-1292
35. Caminos JE, Nogueiras R, Blanco M et al (2003) Cellular distribution and regulation of ghrelin messenger ribonucleic acid in the rat pituitary gland. Endocrinology 144:5089-5097